Definitive Healthcare's biggest risks in the FY2024 10-K
- The company relies heavily on subscription revenue from healthcare commercial intelligence platforms and data feeds.
- Operations face intense competition, data access dependencies, and profitability hurdles with significant net losses.
- Regulatory, privacy, and artificial intelligence integration risks could harm reputation and growth.
The risks most specific to Definitive Healthcare
- Risks Related to Our Business and Industry
We generate substantially all of our revenue from sales of subscriptions to our platform and any decline in demand for our platform and the data we offer could have a material adverse effect on our business, financial condition and results of operations
For the year ended December 31, 2024, we derived 97% of our revenue from subscription services, and any decline in demand for our platform could harm our business.
- Risks Related to Our Business and Industry
We may not achieve or sustain profitability in the future as we increase investments in our business or experience operational challenges
For the year ended December 31, 2024, we had a net loss of $591.4 million, compared to a net loss of $289.6 million for 2023.
- Risks Related to Our Business and Industry
We could lose our access to our data providers, which could negatively impact our platform and could have a material adverse effect on our business, financial condition and results of operations
We depend extensively on external data sources, including real-time claims data, and could lose access if our data providers or competitors cut us off.
- Risks Related to Our Business and Industry
Our use of A.I., and the integration of A.I. with our products and services, may not be successful and may present business, compliance, and reputational challenges which could lead to operational or reputational damage, competitive harm, and additional costs
We leverage A.I. in our solutions, which presents risks including flawed algorithms, biased datasets, and compliance challenges that could lead to reputational damage.
- Risks Related to Our Business and Industry
We have undertaken internal restructuring activities, and may do so again in the future. The assumptions underlying these activities may prove to be inaccurate, or we may fail to achieve the expected benefits therefrom
In January 2024, we reduced our global headcount by 154 employees and may undertake further internal restructuring activities that could fail to achieve expected benefits.
- Risks Related to Our Business and Industry
Operations outside the U.S. expose us to risks inherent in international operations
Our Monocl and AW businesses expose us to risks inherent in international operations, including costly expansion and unpredictable market reception.
All 74 risk factors
Headings as the filing states them, in filing order.
Risks Related to Our Business and Industry
- 01We generate substantially all of our revenue from sales of subscriptions to our platform and any decline in demand for our platform and the data we offer could have a material adverse effect on our business, financial condition and results of operations
- 02macroeconomic factors and their impacts on users of healthcare data
- 03The market in which we operate is highly competitive, such that if we do not compete effectively, it could have a material adverse effect on our business, financial condition and results of operations
- 04If we fail to respond to advances in healthcare commercial intelligence, competitors could surpass the depth, breadth or accuracy of our platform
- 05If we are not able to obtain and maintain accurate, comprehensive or reliable data, we could experience reduced demand for our platform
- 06Our growth rates have fluctuated and may not be indicative of our future growth
- 07We may not achieve or sustain profitability in the future as we increase investments in our business or experience operational challenges
- 08We could lose our access to our data providers, which could negatively impact our platform and could have a material adverse effect on our business, financial condition and results of operations
- 09If we are unable to attract new customers and expand subscriptions of current customers, our revenue growth and financial performance will be negatively impacted
- 10Our use of A.I., and the integration of A.I. with our products and services, may not be successful and may present business, compliance, and reputational challenges which could lead to operational or reputational damage, competitive harm, and additional costs
- 11We may fail to offer the optimal pricing and packaging of our solutions, which could negatively impact our growth strategy and ability to effectively compete in the market
- 12If we fail to offer high-quality customer experience, our business and reputation will suffer
- 13Our customers or unauthorized parties could use our platform in a manner that is contrary to our values or applicable law, which could harm our relationships with customers or employees, or expose us to litigation or harm our reputation
- 14potential challenges by governmental authorities, including the U.S. Department of Justice, for anti-competitive or other reasons
- 15If we fail to maintain adequate operational and financial resources, particularly if we grow rapidly, we may be unable to execute our business plan or maintain high levels of service and customer satisfaction
- 16We depend on our executive officers and other key employees, and the loss of one or more of these employees or an inability to attract and retain other highly skilled employees could have a material adverse effect on our business, financial condition and results of operations
- 17If we fail to protect and maintain our brand, our reputation may be harmed and our ability to attract and retain customers will be impaired
- 18A substantial portion of our revenue and cash flows from sales of our subscriptions to our platform to customers in the healthcare ecosystem, and factors that adversely affect it, including health reform measures and mergers within the healthcare ecosystem or regulatory changes, could also adversely affect us
- 19Healthcare companies may be unsuccessful and may subsequently declare bankruptcy. If our customers declare bankruptcy or otherwise dissolve, they may terminate their agreements with us or we may not be able to recoup the full payment of fees owed to us
- 20Changes in the sizes or types of organizations that subscribe to our platform could affect our business and our financial results may fluctuate due to increasing variability in our sales cycles
- 21lengthy and multi-faceted purchasing approval processes
- 22If we have overestimated the size of our total addressable market, our future growth rate may be limited
- 23Our business could be negatively affected by changes in search engine algorithms and dynamics or other traffic-generating arrangements
- 24Operations outside the U.S. expose us to risks inherent in international operations
- 25We have a limited operating history in an evolving industry, which makes it difficult to forecast our revenue and evaluate our business and future prospects
- 26Our failure to raise additional capital or generate cash flows necessary to expand our operations and invest in new technologies in the future could reduce our ability to compete successfully and have a material adverse effect on our business, financial condition and results of operations
- 27We have undertaken internal restructuring activities, and may do so again in the future. The assumptions underlying these activities may prove to be inaccurate, or we may fail to achieve the expected benefits therefrom
- 28Catastrophic events and geopolitical and trade tensions could disrupt our business and adversely affect our operating results
- 29Our solutions utilize open-source software, and any failure to comply with the terms of one or more of these open-source licenses could adversely affect our business
- 30We are subject to subscription and payment processing risk from our third-party vendors and any disruption to such processing systems could have a material adverse effect on our business, financial condition and results of operations
Risks Related to Data Privacy and Cybersecurity
- 31In addition to experiencing a security incident, third parties may gather, collect, or infer sensitive data about us from public sources, data brokers, or other means that reveals competitively sensitive details about our organization and could be used to undermine our competitive advantage or market position
Legal and Regulatory Risks
- 32Our platform addresses heavily regulated functions within the healthcare ecosystem and such regulations and laws are subject to change. Failure to comply with applicable laws and regulations could lessen the demand for our solutions or subject us to significant claims and losses
- 33We are subject to sanctions, export controls, anti-corruption, anti-bribery, anti-money laundering and similar laws, and non-compliance with such laws can subject us to criminal penalties or significant fines and have a material adverse effect on our business, financial condition and results of operations
- 34We could be subject to claims brought by our customers, which could be costly and time consuming to defend
- 35We may be subject to litigation, investigations or other actions, which could harm our reputation and have a material adverse effect on our business, financial condition and results of operations
- 36We may be subject to liability if we breach our contracts, and our insurance may be inadequate to cover our losses
- 37We may be subject to legal liability for collecting, displaying or distributing information
Risks Related to Intellectual Property
- 38We may not be able to adequately protect our proprietary and intellectual property rights in our data analytics or data science
- 39We may be subject to claims by others that we are infringing on their intellectual property rights
- 40Our business could be adversely impacted by changes in laws and regulations related to the Internet or changes in access to the Internet generally
- 41Regulatory and legislative developments related to the use of A.I. could adversely affect our use of such technologies in our products, services, and business and expose us to legal and regulatory risks
Risks Related to Certain Tax Matters
- 42Unanticipated changes in our effective tax rate and additional tax liabilities may impact our financial results
- 43Changes in tax laws or regulations in the various tax jurisdictions we are subject to that are applied adversely to us or our paying customers could increase the costs of our platform and harm our business
- 44Our results of operations may be harmed if we are required to collect sales or other related taxes for subscriptions to our platform in jurisdictions where we have not historically done so
Risks Related to Accounting and Financial Reporting Matters
- 45Deferred revenue and change in deferred revenue may not be accurate indicators of our future financial results
- 46Because we recognize subscription revenue over the subscription term, downturns or upturns in new sales and renewals are not immediately reflected in full in our results of operations
- 47We have broad discretion in the use of our cash and short-term investment balances and may not use them effectively
- 48We have a significant amount of goodwill and intangible assets on our balance sheet, and our results of operations have in the past been and may in the future be adversely affected if we fail to realize the full value of our goodwill and intangible assets
- 49decline in our market capitalization relative to net book value for a sustained period
- 50harmed if we experience problems with any new systems and controls that result in delays in their implementation or increased costs to correct any post-implementation issues that may arise
Risks Related to Our Indebtedness
- 51We may not be able to secure sufficient additional financing on favorable terms, or at all, to meet our future capital needs
- 52Any default under our debt agreements could have significant consequences
- 53The total principal amount of debt outstanding, excluding unamortized debt issuance costs, under the 2021 Credit Agreement as of December 31, 2024 was $244.1 million
- 54exposing us to risks inherent in interest rate fluctuations because our borrowings are at variable rates of interest, which could result in higher interest expense in the event of increases in interest rates
- 55The failure to comply with the covenants under our credit agreements or volatility in the credit and capital markets could have a material adverse effect on our business, financial condition, liquidity and results of operation
Risks Related to Our Organizational Structure
- 56We are a holding company, and our principal asset is our 74.3% ownership interest in Definitive OpCo, and we are accordingly dependent upon distributions from Definitive OpCo to pay dividends, if any, and taxes, make payments under the Tax Receivable Agreement and pay other expenses
- 57In certain circumstances, Definitive OpCo will be required to make distributions to us and the other holders of LLC Units, and the distributions that Definitive OpCo will be required to make may be substantial
- 58In certain cases, payments under the Tax Receivable Agreement to the TRA Parties may be accelerated or significantly exceed any actual benefits we realize in respect of the tax attributes subject to the Tax Receivable Agreement
- 59The acceleration of payments under the Tax Receivable Agreement in the case of certain changes of control may impair our ability to consummate change of control transactions or negatively impact the value received by owners of our Class A Common Stock
- 60We will not be reimbursed for any payments made to the TRA Parties under the Tax Receivable Agreement in the event that any tax benefits are disallowed
Risks Related to Ownership of Our Class A Common Stock
- 61Future offerings of debt or equity securities by us may have a material adverse effect on the market price of our Class A Common Stock
- 62We may not realize the anticipated long-term stockholder value of our stock repurchase program, and any failure to repurchase our common stock after we have announced our intention to do so may negatively impact our stock price
- 63Certain of our directors and stockholders will not have any obligation to present business opportunities to us and may compete with us
- 64Our quarterly results of operations may fluctuate significantly and could fall below the expectations of securities analysts and investors due to seasonality and other factors, some of which are beyond our control, resulting in a decline in our stock price
- 65The market price and trading volume of our Class A Common Stock has been and may continue to be volatile, which could result in rapid and substantial losses for our stockholders, and you may lose all or part of your investment
- 66general market, political and economic conditions, including local conditions in the markets in which we operate
- 67The market price of our Class A Common Stock could be negatively affected by sales of substantial amounts of our Class A Common Stock in the public markets
- 68The future issuance of additional Class A Common Stock in connection with any equity plans, acquisitions or otherwise will dilute all other stockholdings
- 69As a public company, we incur significant costs to comply with the laws and regulations affecting public companies, which could harm our business and results of operations
- 70Concentration of ownership of our common stock among our existing executive officers, directors, and principal stockholders may prevent new investors from influencing significant corporate decisions
- 71Delaware law and our organizational documents, as well as our existing and future debt agreements, may impede or discourage a takeover, which could deprive our investors of the opportunity to receive a premium for their shares
- 72prohibit our stockholders from acting by written consent once Advent’s ownership falls below 30%; and establish advance notice requirements for nominations for election to our Board or for proposing matters that can be acted on by stockholders at stockholder meetings
- 73Claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available to us
- 74Our ability to issue preferred stock may deter takeover attempts
Other Definitive Healthcare 10-Ks
- FY2025 10-K risk factors71 risks1 new4 dropped8 reworded
The company added acquisition risks and updated multi-year goodwill impairment figures totaling $196.1 million in 2025. Stock volatility and Tax Receivable Agreement disclosures were updated with minor terminology changes. Financial control weaknesses and limited operating history risks were dropped.
Filed Feb 26, 2026
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.